About this medicine
- Approved name
- Norditropin
- International non-proprietary name (INN) or common name
- somatropin
- Associated names
- Norditropin FlexPro
- Norditropin NordiFlex
- Norditropin SimpleXx
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-13/1304
- Type
- Article 13 referrals
This type of referral is triggered for a medicine that has been authorised by mutual recognition or via the decentralised procedure when there is disagreement between Member States on a variation (type II), on the grounds of a potential serious risk to public health.
Key dates and outcomes
- CHMP opinion date
- 15/12/2011
- EC decision date
- 06/03/2012